These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15936513)

  • 1. Striatal dopamine during sensorial stimulations: a [18F]FDOPA PET study in human and cats.
    Hassoun W; Thobois S; Ginovart N; Garcia-Larrea L; Cavorsin ML; Guillouet S; Bonnefoi F; Costes N; Lavenne F; Martin JP; Broussolle E; Leviel V
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):63-7. PubMed ID: 15936513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography.
    Tiihonen J; Vilkman H; Räsänen P; Ryynänen OP; Hakko H; Bergman J; Hämäläinen T; Laakso A; Haaparanta-Solin M; Solin O; Kuoppamäki M; Syvälahti E; Hietala J
    Mol Psychiatry; 1998 Mar; 3(2):156-61. PubMed ID: 9577840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli.
    Siessmeier T; Kienast T; Wrase J; Larsen JL; Braus DF; Smolka MN; Buchholz HG; Schreckenberger M; Rösch F; Cumming P; Mann K; Bartenstein P; Heinz A
    Eur J Neurosci; 2006 Jul; 24(1):305-13. PubMed ID: 16882026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.
    Rinne OJ; Nurmi E; Ruottinen HM; Bergman J; Eskola O; Solin O
    Synapse; 2001 Jun; 40(3):193-200. PubMed ID: 11304757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA.
    Cropley VL; Fujita M; Bara-Jimenez W; Brown AK; Zhang XY; Sangare J; Herscovitch P; Pike VW; Hallett M; Nathan PJ; Innis RB
    Psychiatry Res; 2008 Jul; 163(2):171-82. PubMed ID: 18504119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal 18F-dopa uptake: absence of an aging effect.
    Eidelberg D; Takikawa S; Dhawan V; Chaly T; Robeson W; Dahl R; Margouleff D; Moeller JR; Patlak CS; Fahn S
    J Cereb Blood Flow Metab; 1993 Sep; 13(5):881-8. PubMed ID: 8360294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge.
    Vernaleken I; Kumakura Y; Cumming P; Buchholz HG; Siessmeier T; Stoeter P; Müller MJ; Bartenstein P; Gründer G
    Neuroimage; 2006 May; 30(4):1332-9. PubMed ID: 16439159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sensory stimulus on striatal dopamine release in humans and cats: a [(11)C]raclopride PET study.
    Thobois S; Hassoun W; Ginovart N; Garcia-Larrea L; Le Cavorsin M; Guillouet S; Bonnefoi F; Costes N; Lavenne F; Broussolle E; Leviel V
    Neurosci Lett; 2004 Sep; 368(1):46-51. PubMed ID: 15342132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vivo measurement of LDOPA uptake, dopamine reserve and turnover in the rat brain using [18F]FDOPA PET.
    Walker MD; Dinelle K; Kornelsen R; McCormick S; Mah C; Holden JE; Farrer MJ; Stoessl AJ; Sossi V
    J Cereb Blood Flow Metab; 2013 Jan; 33(1):59-66. PubMed ID: 22929441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of striatal dopamine synthesis capacity to age and cognition.
    Braskie MN; Wilcox CE; Landau SM; O'Neil JP; Baker SL; Madison CM; Kluth JT; Jagust WJ
    J Neurosci; 2008 Dec; 28(52):14320-8. PubMed ID: 19109513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of an 18F-labeled dopa prodrug as a PET tracer for studying brain dopamine metabolism.
    Ishiwata K; Shinoda M; Ishii S; Nozaki T; Senda M
    Nucl Med Biol; 1996 Apr; 23(3):295-301. PubMed ID: 8782240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of 6-[18F]fluorodopa uptake decline in striatal subregions in Parkinson's disease.
    Gallagher CL; Oakes TR; Johnson SC; Chung MK; Holden JE; Bendlin BB; McLaren DG; Xu G; Nickles RJ; Pyzalski R; DeJesus O; Brown WD
    Mov Disord; 2011 Mar; 26(4):614-20. PubMed ID: 21449008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
    Ishikawa T; Dhawan V; Kazumata K; Chaly T; Mandel F; Neumeyer J; Margouleff C; Babchyck B; Zanzi I; Eidelberg D
    J Nucl Med; 1996 Nov; 37(11):1760-5. PubMed ID: 8917170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study.
    Brück A; Aalto S; Nurmi E; Vahlberg T; Bergman J; Rinne JO
    Mov Disord; 2006 Jul; 21(7):958-63. PubMed ID: 16550545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal "function-metabolism" mismatch on F-18 FDG/F-18 FDOPA PET/CT.
    Tripathi M; Sharma R; Jaimini A; Garg G; Khurana A; D'Souza M; Varshney R; Mishra A; Mondal A
    Clin Nucl Med; 2009 Oct; 34(10):703-5. PubMed ID: 19893408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice.
    Honer M; Hengerer B; Blagoev M; Hintermann S; Waldmeier P; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2006 Jul; 33(5):607-14. PubMed ID: 16843835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.
    Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK
    Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Striatal Dopamine Synthesis Capacity in Gambling Addiction.
    van Holst RJ; Sescousse G; Janssen LK; Janssen M; Berry AS; Jagust WJ; Cools R
    Biol Psychiatry; 2018 Jun; 83(12):1036-1043. PubMed ID: 28728675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower dopamine tone in the striatum is associated with higher body mass index.
    Lee Y; Kroemer NB; Oehme L; Beuthien-Baumann B; Goschke T; Smolka MN
    Eur Neuropsychopharmacol; 2018 Jun; 28(6):719-731. PubMed ID: 29705023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia.
    Huttunen J; Heinimaa M; Svirskis T; Nyman M; Kajander J; Forsback S; Solin O; Ilonen T; Korkeila J; Ristkari T; McGlashan T; Salokangas RK; Hietala J
    Biol Psychiatry; 2008 Jan; 63(1):114-7. PubMed ID: 17655830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.